Botanic Selective Estrogen Receptor Modulators (SERMs) and Venous Thrombo Emboli (VTE)
نویسندگان
چکیده
Botanic Selective Estrogen Receptor Modulators (SERMs) and Venous Thrombo Emboli (VTE) Arnon Blum1*, Shira Shoher1, Andrei Adler2, Doron Ben David2, Shay Yeganeh1 1Department of Medicine Baruch Padeh Poria Hsopital Bar Ilan University, Israel 2Department of Imaging, Baruch Padeh Poria Hsopital Bar Ilan University, Israel *Corresponding author: Dr. Arnon Blum, Department of Medicine, Baruch Padeh Poria Hospital Bar Ilan University, Lower Galilee 15208, Israel, Tel: 97246652688; Email: [email protected] Received: 09-10-2015 Accepted: 09-24-2015 Published: 09-29-2015 Copyright: © 2015 Arnon Case Report
منابع مشابه
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
Selective estrogen receptor modulators (SERMs) represent a class with a growing number of compounds that act as either estrogen receptor agonists or antagonists in a tissue-specific manner. This article reviews lasofoxifene, a new-generation SERM that has completed phase III development for the prevention and treatment of osteoporosis in postmenopausal women. Consistent with preclinical observa...
متن کاملThe evolution of selective estrogen receptor modulators in osteoporosis therapy
Selective estrogen receptor modulators (SERMs), which exhibit estrogen receptor agonist or antagonist activity based on the target tissue, have evolved through multiple generations for the prevention and/or treatment of postmenopausal osteoporosis. An ideal SERM would protect bone without stimulating the breast or endometrium. Raloxifene, lasofoxifene, and bazedoxifene have demonstrated unique ...
متن کاملLong-term toxicities of selective estrogen-receptor modulators and antiaromatase agents.
Published literature indicates that the selective estrogen-receptor modulators (SERMs) tamoxifen and raloxifene (Evista) have favorable effects on bone density, lipid profiles, and the incidence of second breast cancers, and unfavorable effects on the incidence of venous thrombosis and hot flushes. Tamoxifen increases the risk of endometrial cancer, but raloxifene does not. The effects of SERMs...
متن کاملThe risk for cardiovascular disease in women: from estrogens to selective estrogen receptor modulators.
Cardiovascular disease, a generic denomination including coronary heart disease (CHD), stroke, and venous thromboembolic disease (VTED), has shown sensitivity to estrogens. The relative protection of women as compared with men has nourished a debate about a possible protective role for estrogens, but the prejudicial effects detected in clinical trials has created confusion on the risk/benefit r...
متن کاملSERMs in the prevention and treatment of postmenopausal osteoporosis: an update.
Selective estrogen receptor modulators (SERMs) have the ability to bind the estrogen receptor (ER) and are known to confer ER agonist or antagonist effects depending on the target tissue. A number of newer SERMs, including bazedoxifene, lasofoxifene and ospemifene, are currently under clinical development for the prevention and treatment of postmenopausal osteoporosis and for other indications....
متن کامل